Search results
Results from the WOW.Com Content Network
Antiplatelet drugs are widely used in primary and secondary prevention of thrombotic disease, especially myocardial infarction and ischemic stroke. [1] Antiplatelet therapy with one or more of these drugs decreases the ability of blood clots to form by interfering with the platelet activation process in primary hemostasis. Antiplatelet drugs ...
Anticoagulants are considered more aggressive than antiplatelet drugs. [34] Anticoagulants work by interfering with various clotting factors to lengthen the time for coagulation. This can be achieved by either reducing the formation of bioactive clotting factors or accelerating the inactivation of clotting factors.
Anticoagulants in acute coronary syndrome are targeted against the coronary blood clot, as well as towards prevention of thrombotic complications, like formation of blood clots in the ventricles, stroke, pulmonary embolism or deep vein thrombosis. [49] Patients undergoing PCI also need an anticoagulant to prevent catheter thrombosis.
An antithrombotic agent is a drug that reduces the formation of blood clots (). [1] [2] Antithrombotics can be used therapeutically for prevention (primary prevention, secondary prevention) or treatment of a dangerous blood clot (acute thrombus).
Antifibrinolytics are a class of medication that are inhibitors of fibrinolysis. [1] Examples include aminocaproic acid (ε-aminocaproic acid) and tranexamic acid.These lysine-like drugs interfere with the formation of the fibrinolytic enzyme plasmin from its precursor plasminogen by plasminogen activators (primarily t-PA and u-PA) which takes place mainly in lysine rich areas on the surface ...
antiplatelet [45] [41] ticlid: enoxaparin: anticoagulant activation of antiprothrombin, prevents fibrin formation slow IV platelet count is monitored [45] [41] dalteparin: anticoagulant activation of antiprothrombin, prevents fibrin formation IV [41] fondaparinux: anticoagulant inhibits thrombin production injection aspirin not recommended with ...
Thrombolysis, also called fibrinolytic therapy, is the breakdown of blood clots formed in blood vessels, using medication. It is used in ST elevation myocardial infarction , stroke , and in cases of severe venous thromboembolism (massive pulmonary embolism or extensive deep vein thrombosis ).
In patients undergoing primary percutaneous coronary intervention (PCI) for an ST-segment elevation myocardial infarction (STEMI), US, [12] European, [13] and Canadian [14] guidelines recommend that a P2Y 12 inhibitor should be administered as soon as possible, although it is unclear whether administration of these medications before the patient arrives at the hospital confers additional ...